Skip to main content
Clinical Trials/RBR-36qz3p
RBR-36qz3pCompleted未知

Evaluation of the Effectiveness of Simvastatin Use in Systemic Sclerosis Patients: A Pragmatic Clinical Trial - Use of simvastatin in patients with systemic sclerosis: a randomized clinical trial

Sociedade Brasileira de Reumatologia0 sitesStarted: September 30, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Intervention

Eligibility Criteria

Ages
18Y to 70Y (—)

Inclusion Criteria

  • Diagnosis of Systemic Sclerosis according to the American College of Rheumatology; minimum and maximum age between eighteen and seventy years of age; serum total cholesterol levels up to 200mg/dl; written consent to participate in the study

Exclusion Criteria

  • Pregnant women; intolerance or allergy to simvastatin or its derivatives; being in use or having used it for less than 30 days; diabetes mellitus; heart failure; renal failure; hypertension; myopathies; hypothyroidism; smoking

Investigators

Sponsor
Sociedade Brasileira de Reumatologia

Similar Trials

Evaluation of the efficacy of simvastatin... | Clinical Trial